ALLIANCE PHARMA PLC

Report Publication Announcement • Apr 28, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5754W

Alliance Pharma PLC

28 April 2016

For immediate release	28 April 2016

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Annual Report and AGM Notice

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces that its 2015 Annual Report and Accounts and Notice of Annual General Meeting, which will be held on 25 May 2016, are now available on the Company's website at www.alliancepharma.co.uk.

Printed copies of both documents will be posted to shareholders shortly and may also be requested by email at ir@alliancepharma.co.uk.

For further information:

### Alliance Pharma plc	### + 44 (0) 1249 466966
John Dawson, Chief Executive Andrew Franklin, Chief Financial Officer
Sarah Robinson, Company Secretary
www.alliancepharma.co.uk
### Buchanan	### + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane Glover
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: David Poutney / James Black

Notes to Editors:

About Alliance Pharma

Alliance, founded in 1998, is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors.  Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCFMGZDVNVGVZM